One page, thousands of outlets. See who else covered it.
Shares of Moderna and Merck soared on Wednesday morning after a study showed that a vaccine they produced had promising results when it comes to fighting skin cancer. A late-stage trial showed that the mRNA vaccine helped reduce the recurrence of melanoma. Sam Fazeli of Bloomberg Intelligence has more. (Source: Bloomberg)
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
Market volatility shapes how investors experience the financial world. Prices rise and fall based on economic signals, company performance, and global events.
Publication provides public notice of TMC USA’s consolidated exploration and commercial recovery application for TMC USA-A Submitted earlier this year, the consolidated application covers areas…
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
